arrow
M

Mazie Tsang

mayo clinic
H指数:12
被引数:905

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma

接受双特异性抗体治疗的复发/难治性滤泡性淋巴瘤和弥漫大B细胞淋巴瘤患者的报告时间毒性

2026-05-210
OA
Evaluating Vulnerable Elders Survey-13 and FIL Geriatric Assessment in Older Adults With Aggressive Lymphomas

评估易损老年人调查问卷-13和FIL老年综合评估在侵袭性淋巴瘤老年患者中的应用

2026-02-010
PRE
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience

慢性淋巴细胞白血病(CLL)患者中Richter转化的中枢神经系统受累:梅奥诊所的经验

2026-01-070
OAAI
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort

自评生成的Charlson合并症指数在淋巴瘤结局流行病学(LEO)队列中的适应性和表现

2025-10-070
PRE
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis

高计数单克隆B细胞淋巴细胞增多症中影像学研究在预测首次治疗时间及总生存期方面的作用

2025-07-150
PRE
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study

比较年龄≥80岁慢性淋巴细胞白血病(CLL)老年患者一线疗法:一项梅奥诊所与丹麦全国性研究

2025-06-180
PRE
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism
2025-01-010
PRE
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era
LEUKEMIA
IF13.4
2024-12-100
PRE
Understanding the Patient Perspective on Treatment Preferences for Follicular Lymphoma

理解患者对滤泡性淋巴瘤治疗偏好的视角

BLOOD
IF23.1
2024-11-050
PRE
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study
2024-04-261
OAAI
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 US cancer centers
2023-04-0512
OA